Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
Publication
Beyond Pigment Loss: Three Therapeutic Objectives in Vitiligo
Vitiligo entails three therapeutic objectives: control of autoimmune activity, restoration of melanocyte function, and interruption of disease memory. Distinguishing these goals can refine clinical management, trial endpoints, and therapeutic development in vitiligo and other immune-mediated skin diseases.
Published in: International Journal of Dermatology
Date: 15 September 2026
Beyond Pigment Loss: Three Therapeutic Objectives in Vitiligo
Yan Valle, Torello Lotti, Julia Sigova, Davinder Parsad
FAQOther Questions
- What are risks of oral and topical corticosteroids?
Corticosteroid drugs (like hydrocortisone, and others) are often used for treating vitiligo. By mimicing the effects of hormones your body produces naturally in your adrenal gla...
- Which is better for judging vitiligo — Wood’s lamp or dermoscopy?
A recent study out of India compared the two head-to-head. Both tools correlated fairly well with clinical criteria, but dermoscopy had a slight edge: Wood’s lamp: sensitivity 7...
- What are the best predictors for therapy response in vitiligo?
A fair question. Also a slightly annoying one, because dermatology loves nuance and patients usually want something more like a weather forecast. Still, a few factors do show up...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.